Who are Nanobiotix S.A.'s main suppliers?

Nanobiotix S.A. (NBTX) key suppliers include: HEALTHCARE-ROYALTY-PARTNERS, BPIFRANCE-FINANCEMENT, EUROPEAN-INVESTMENT-BANK, HSBC-FRANCE, Johnson & Johnson and 5 more. View the full supplier network at chainsifter.com/chain/NBTX.

Who are Nanobiotix S.A.'s major customers?

Nanobiotix S.A. (NBTX) key customers include: JANSSEN, MD-ANDERSON-CANCER-CENTER-OF-THE-UNIVERSITY-OF-T, Johnson & Johnson, Johnson & Johnson, NNBXF and 3 more. View the full customer network at chainsifter.com/chain/NBTX.

What sector is Nanobiotix S.A. in?

Nanobiotix S.A. (NBTX) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

NBTX Supply Chain: Nanobiotix S.A. Supplier List & 19 Relationships

10Suppliers

8Customers

1Debt Items

20Related Chains

Nanobiotix S.A. Suppliers

Ticker	Name	Confidence	Evidence
HEALTHCARE-ROYALTY-PARTNERS	HEALTHCARE-ROYALTY-PARTNERS	90%	the royalty financing agreement signed in October 2025 with HealthCare Royalty Partners
BPIFRANCE-FINANCEMENT	BPIFRANCE-FINANCEMENT	80%	The Group has entered into loan agreements with the European Investment Bank, Bpifrance Financement and HSBC France
EUROPEAN-INVESTMENT-BANK	EUROPEAN-INVESTMENT-BANK	80%	A default in payment or a breach of certain covenants of all or part of these loans, including due to a request for early repayment by the European Investment Bank
HSBC-FRANCE	HSBC-FRANCE	80%	The Group has entered into loan agreements with the European Investment Bank, Bpifrance Financement and HSBC France
JNJ	Johnson & Johnson	72%	As part of the release and termination agreement executed by and between the Company and this financial service provider as of July 19, 2023, and in addition to the amounts already paid in 2023, the …
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from NBTX graph: As part of the release and termination agreement executed by and between the Company and this financial service provid…
NNBXF	NNBXF	72%	Reciprocal relationship from NNBXF graph: Reciprocal relationship from NBTX graph: he plans to meet its future operating cash flow requirements are not sufficient to fund necessary expenditures and m…
NNBXF	NNBXF	72%	he plans to meet its future operating cash flow requirements are not sufficient to fund necessary expenditures and meet our financial obligations as they come due, the Company’s liquidity, financial …
SNYNF	Sanofi	72%	or the year ended December 31, 2023 (€12.5 million), favorably decreased by €24.6 million compared to the net cash used in operating activities in 2022 (€37.1 million), primarily due to the collectio…
SNYNF	Sanofi	72%	Reciprocal relationship from SNYNF graph: Reciprocal relationship from NBTX graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from NBTX graph: or the year ended December 31, 20…

Nanobiotix S.A. Customers

Ticker	Name	Confidence	Evidence
JANSSEN	JANSSEN	90%	and the License Agreement with Janssen
MD-ANDERSON-CANCER-CENTER-OF-THE-UNIVERSITY-OF-T	MD-ANDERSON-CANCER-CENTER-OF-THE-UNIVERSITY-OF-T	90%	including those trials to be conducted or being initiated under our collaborations with MD Anderson Cancer Center of the University of Texas
JNJ	Johnson & Johnson	72%	rom € million as of December 31, 2023 to € million as of December 31, 2024, mainly due to bonus accruals decrease of € million. 14.3. Deferred income and contract liabilities Current contract liabili…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from NBTX graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from NBTX graph: Reciprocal relationship from JNJ grap…
NNBXF	NNBXF	72%	he plans to meet its future operating cash flow requirements are not sufficient to fund necessary expenditures and meet our financial obligations as they come due, the Company’s liquidity, financial …
NNBXF	NNBXF	72%	Reciprocal relationship from NNBXF graph: Reciprocal relationship from NBTX graph: Reciprocal relationship from NNBXF graph: Reciprocal relationship from NBTX graph: Reciprocal relationship from NNBX…
SNYNF	Sanofi	72%	the ‘‘modified retrospective method’’ starting on January 1, 2019 and recorded rights of use assets and lease liabilities for the amounts of the discounted lease payments outstanding for the remainde…
SNYNF	Sanofi	72%	Reciprocal relationship from SNYNF graph: Reciprocal relationship from NBTX graph: the ‘‘modified retrospective method’’ starting on January 1, 2019 and recorded rights of use assets and lease liabil…

Nanobiotix S.A. Debt Obligations

Instrument	Description	Confidence	Evidence
NBTX-DEBT	Debt stack $110.9M	90%	Market cache reports total debt of $110.9M.

Nanobiotix S.A. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Nanobiotix S.A..

Nanobiotix S.A. Ownership

Holder	Name	Confidence	Evidence
NBTX-OWNER-JOHNSON-JOHNSON	JOHNSON & JOHNSON	90%	13F overlay lists JOHNSON & JOHNSON as top holder; 16 tracked holders.

Nanobiotix S.A. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
AORT	Artivion, Inc.	100.00	2
CANG	Cango Inc.	100.00	2
ANRO	Alto Neuroscience, Inc.	100.00	2
BLNE	Beeline Holdings, Inc.	100.00	2
GEMI	Gemini Space Station, Inc.	100.00	2
BRBI	BRBI BR Partners S.A.	100.00	2
BLRX	BioLineRx Ltd.	100.00	2
ALXO	ALX Oncology Holdings Inc.	100.00	2
BSX	Boston Scientific Corporation	100.00	2
BLSH	Bullish	100.00	2
AVBP	ArriVent BioPharma, Inc.	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
WHWK	Whitehawk Therapeutics, Inc.	100.00	2
CTMX	CytomX Therapeutics, Inc.	100.00	2
ANIK	Anika Therapeutics, Inc.	100.00	2
BLLN	BillionToOne, Inc.	100.00	2
AMBR	Amber International Holding Limited	100.00	2
ANL	Adlai Nortye Ltd.	100.00	2
BTDR	Bitdeer Technologies Group	100.00	2
ENLT	Enlight Renewable Energy Ltd	100.00	2

Nanobiotix S.A. Supply Chain